Current clinical therapies for cartilage repair, their limitation and the role of stem cells

Current Stem Cell Research and Therapy

Volumn 7, Issue 2, 2012, Pages 143-148

  Dhinsa, Baljinder S ^a   Adesida, Adetola B ^b  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Fibrocartilage; Hyaline cartilage; Knee; Mesenchymal stem cells; Osteoarthritis; Osteochondral defect

Indexed keywords

ABRASION ARTHROPLASTY; ADIPOSE TISSUE; ARTICLE; ARTICULAR CARTILAGE; AUTOLOGOUS CHONDROCYTE IMPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHONDROGENESIS; CHONDROPATHY; FIBROCARTILAGE; HUMAN; HYALINE CARTILAGE; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MORBIDITY; PRIORITY JOURNAL; SYNOVIUM;

ADULT; CARTILAGE, ARTICULAR; HUMANS; OSTEOARTHRITIS; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING;

EID: 84857770165     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488812799219009     Document Type: Article

References (82)

1. Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 2002; 10: 432-63.
2. Buckwalter JA, Mankin HJ. Articular cartilage repair and transplantation. Arthritis Rheum 1998; 41: 1331-42.
3. Steinert AF, Ghivizzani SC, Rethwilm A, Tuan RS, Evans CH, Noth U. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 2007; 9(3): 213-27.
4. Mobasheri A, Csaki C, Clutterbuck AL, Rahmanzadeh M, Shakibaei M. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histol Histopathol 2009; 24(3): 347-66.
5. Convery FR, Akeson WH, Keown GH. The repair of large osteochondral defects. An experimental study in horses. Clin Orthop Relat Res 1972; 82: 253-62.
6. Mankin HJ. The response of articular cartilage to mechanical injury. J Bone Joint Surg Am 1982; 64: 460-6.
7. Caplan AI, Elyaderani M, Mochizuki Y, Wakitani S, Goldberg VM. Principles of cartilage repair and regeneration. Clin Orthop 1997; 342: 254-69.
8. Koga H, Engebretsen L, Brinchmann JE, Muneta T, Sekiya I. Mesenchymal stem cell-based therapy for cartilage repair: a review. Knee Surg Sports Traumatol Arthrosc 2009; 17: 1289-97.
9. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1993; 75; 532-53.
10. Redman SN, Oldfield SF, Archer CW. Current strategies for articular cartilage repair. European Cells and Materials 2005; 9: 23-32.
11. Schumann D, Kujat R, Nerlich M, Angele P. Mechanobiological conditioning of stem cells for cartilage tissue engineering. Biomed Mater Eng 2006; 16(4 Suppl): S37-52.
12. Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, Rodkey WG. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy 2003; 19: 477-84.
13. Hangody L, Kish G, Karpati Z, Szerb I, Udvarhelyi I. Arthroscopic autogenous osteochondral mosaicplasty for the treatment of femoral condylar articular defects. A preliminary report. Knee Surg Sports Traumatol Arthrosc 1997; 5: 262-7.
14. Czitrom AA, Langer F, McKee N, Gross AE. Bone and cartilage allotransplantation. A review of 14 years of research and clinical studies. Clin Orthop 1986; 208: 141-5.
15. Tomford WW, Springfield DS, Mankin HJ. Fresh and frozen articular cartilage allografts. Orthopedics 1992; 15: 1183-8.
16. Hangody L, Rathonyi GK, Duska Z, Vasarhelyi G, Fules P, Modis L. Autologous osteochondral mosaicplasty. Surgical technique. J Bone Joint Surg Am 2004; 86-A Suppl: 65-72.
17. Stevenson S. The immune response to osteochondral allografts in dogs. J Bone Joint Surg Am 1987; 69: 573-82.
18. Carranza-Bencano A, Perez-Tinao M, Ballesteros-Vazquez P, Armas-Padron JR, Hevia-Alonso A, Martos Crespo F. Comparative study of the reconstruction of articular cartilage defects with free costal perichondrial grafts and free tibial periosteal grafts: an experimental study on rabbits. Calcif Tissue Int 1999; 65: 402-7.
19. Bartlett W, Skinner JA, Gooding CR, et al. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br 2005; 87-B: 640-5.
20. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331: 889-95.
21. Minas T. Chondrocyte implantation in the repair of chondral lesions of the knee: economics and quality of life. Am J Orthop 1998; 27: 739-44.
22. Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, Lindahl A. Two-to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop 2000; 374: 212-34.
23. Peterson L, Vasiliadis HS, Brittberg M, Lindahl A. Autologous Chondrocyte Implantation. A Long-term Follow-up. Am J Sports Med 2010; 38(6): 1117-24.
24. Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982; 30: 215-24.
25. Haddo O, Mahroof S, Higgs D, et al. The use of chondrogide membrane in autologous chondrocyte implantation. Knee 2004; 11: 51-5.
26. Kreuz PC, Steinwachs M, Erggelet C, et al. Classification of graft hypertrophy after autologous chondrocyte implantation of fullthickness chondral defects in the knee. Osteoarthritis Cartilage 2007; 15: 1339-47.
27. Gigante A, Bevilacqua C, Ricevuto A, Mattioli-Belmonte M, Greco F. Membrane-seeded autologous chondrocytes: cell viability and characterization at surgery. Knee Surg Sports Traumatol Arthrosc 2007; 15: 88-92.
28. Bachmann G, Basad E, Lommel D, Steinmeyer J. MRI in the follow- up of matrix-supported autologous chondrocyte transplantation (MACI) and microfracture. Radiologe 2004; 44: 773-82.
29. Grande DA, Halberstadt C, Naughton G, Schwartz R, Manji R. Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J Biomed Mater Res 1997; 34: 211-20.
30. Ronga M, Grassi FA, Bulgheroni P. Arthroscopic autologous chondrocyte implantation for the treatment of a chondral defect in the tibial plateau of the knee. Arthroscopy 2004; 20: 79-84.
31. Beresford JN, Joyner CJ, Devlin C, Triffitt JT. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 1994; 39: 941-7.
32. Gregoire FM. Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med 2001; 226: 997-1002.
33. MacDougald OA, Mandrup S. Adipogenesis: forces that tip the scales. Trends Endocrinol Metab 2002; 13: 5-11.
34. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochem 1992; 97: 493-7.
35. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
36. Rim JS, Mynatt RL, Gawronska-Kozak B. Mesenchymal stem cells from the outer ear: a novel adult stem cell model system for the study of adipogenesis. FASEB J 2005; 19: 1205-7.
37. Zuk PA, Zhu M, Mizino H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-28.
38. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 2000; 16: 145-71.
39. Khan WS, Malik AA, Hardingham TE. Stem Cell Applications and Tissue Engineering Approaches in Surgical Practice. J Perioper Pract 2009; 19(4): 130-5.
40. Nimura A, Muneta T, Koga H, et al. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum 2008; 58: 501-10.
41. Park J, Gelse K, Frank S, von der Mark K, Aigner T, Schneider H. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/ periosteum- and fat-derived cells. J Gene Med 2006; 8: 112-25.
42. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005: 52: 2521-9.
43. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 2005; 23: 1383-9.
44. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 2007; 25: 750-60.
45. Rider DA, Dombrowski C, Sawyer AA, et al. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adiposederived mesenchymal stem cells. Stem Cells 2008; 26: 1598-608.
46. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002; 20: 530-41.
47. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007; 327: 449-62.
48. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000; 97: 3213-18.
49. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267-74.
50. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004; 8(3): 301-16.
51. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H. Smad3 induces chondrogenesis through the activation of SOX9 via CREBbinding protein/p300 recruitment. J Biol Chem 2005; 280: 8343-50.
52. Magne D, Vinatier C, Julien M, Weiss P, Guicheux J. Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol Med 2005; 11: 519-26.
53. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor SOX9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for the expression of SOX5 and SOX6. Genes Dev 2002; 16: 2813-28.
54. Adesida AB, Brady LM, Khan WS, Hardingham TE. The matrix forming phenotype of human meniscus cells is enhanced by expansion in the presence of fibroblast growth factor 2 and hypoxia. Arthritis Res Ther 2006; 8: R61.
55. Gidado S, Khan WS, Marsh DR. The Effect of Changes in Oxygen Tension During Fracture Repair on Mesenchymal Stem Cell and Bone Activities. Current Research Journal of Biological Sciences 2009; 1(1): 7-10.
56. Khan WS, Adesida AB, Tew SR, Lowe ET, Hardingham TE. Bone Marrow Derived Mesenchymal Stem Cells Express the Pericyte Marker 3G5 in Culture and Show Enhanced Chondrogenesis in Hypoxic Conditions. J Orthop Res 2010; 28(6): 834-40.
57. Khan WS, Adesida AB, Hardingham TE. Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther 2007; 9: R55.
58. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrowderived stem cells. Stem Cells 2004; 22: 487-500.
59. Ashhurst DE, Ashton BA, Owen ME. The collagens and glycosaminoglycans of the extracellular matrices secreted by bone marrow stromal cells cultured in vivo in diffusion chambers. J Orthop Res 1990; 8: 741-9.
60. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998; 238: 265-72.
61. Gelse K, von der Mark K, Aigner T, Park J, Schneider H. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum 2003; 48: 430-41.
62. Nawata M, Wakitani S, Nakaya H, et al. Use of bone morphogenetic protein 2 and diffusion chambers to engineer cartilage tissue for the repair of defects in articular cartilage. Arthritis Rheum 2005; 52: 155-63.
63. Sekiya I, Colter DC, Prockop DJ. BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem Biophys Res Commun 2001; 284: 411-8.
64. Gelse K, Schneider H. Ex vivo gene therapyapproaches to cartilage repair. Adv Drug Deliv Rev 2006; 58: 259-84.
65. Charriere G, Bejot M, Schnitzler L, Ville G, Hartmann DJ. Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients. J Am Acad Dermatol 1989; 21: 1203-8.
66. Arinzeh TL, Peter SJ, Archambault MP, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003; 85-A: 1927-35.
67. Song L, Chau L, Sakamoto Y, Nakashima J, Koide M, Tuan RS. Electric field-induced molecular vibration for noninvasive, highefficiency DNA transfection. Mol Ther 2004; 9: 607-16.
68. Yan H, Yu C. Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. Arthroscopy 2007; 23: 178-87.
69. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994; 76: 579-92.
70. Adachi N, Sato K, Usas A, et al. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defect. J Rheumatol 2002; 29: 1920-30.
71. Quintavalla J, Uziel-Fusi S, Yin J, et al. Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects. Biomaterials 2002; 23; 109-19.
72. Caterson EJ, Nesti LJ, Li WJ, et al. Three-dimensional cartilage formation by bone marrow-derived cells seeded in polylactide/ alginate amalgam. J Biomed Mater Res 2001; 57: 394-03.
73. Jones EA, Kinsey SE, English A, et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002; 46: 3349-60.
74. Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, Martens UM. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 2003; 17: 1146-9.
75. Simonsen JL, Rosada C, Serakinci N, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002; 20: 592-6.
76. Gronthos S, Chen S, Wang CY, Robey PG, Shi S. Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin. J Bone Miner Res 2003; 18: 716-22.
77. Loty S, Forest N, boulekbache H, Sautier JM. Cytochalasin D induces changes in cell shape and promotes in vitro chondrogenesis: a morphological study. Biol Cell 1995; 83: 149-61.
78. Khan WS, Tew SR, Adesida AB, Hardingham TE. Human infrapatellar fat pad-derived stem cells express the pericyte marker 3G5 and show enhanced chondrogenesis after expansion in fibroblast growth factor-2. Arthritis Res Ther 2008; 10: R74.
79. Wroblewski J, Edwall-Arvidsson C. Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J Bone Miner Res 1995; 10: 735-42.
80. Tew SR, Hardingham TE. Regulation of SOX9 mRNA in Human Articular Chondrocytes Involving p38 MAPK Activation and mRNA Stabilization. J Biol Chem 2006; 281: 39471-9.
81. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36: 568-84.
82. Pelttari K, Winter A, Steck E, et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 2006; 54(10): 3254-66.